Pubblicazioni

4-{3-[(Pyridin-4-ylmethyl)amino]-[1,2,4]triazolo[4,3-b][1,2,4]triazin-6-yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator

2024 - ARCHIV DER PHARMAZIE
Khatir, Z. Z.; Di Sotto, A.; Percaccio, E.; Tuylu Kucukkilinc, T.; Ercan, A.; Chippindale, A. M.; Valipour, M.; Irannejad, H.

Drug transporters and multiple drug resistance in the most common pediatric solid tumors

2016 - CURRENT DRUG METABOLISM
Fruci, D; and Cho, Wcs; Romania, P; and Nobili, V; and Locatelli, F; and Alisi, A.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma